Video Series

The treatment landscape for HIV is discussed by a panel led by Dr Welch.

Key opinion leaders discuss the influence of guideline-directed therapy in the treatment of patients with HIV.

Vaccine hesitancy is a significant barrier to optimal RSV vaccine rollout.

Experts discuss strategies to prepare for the oncoming respiratory diseases season.

Dr Filer highlights the considerations for the rollout of new RSV vaccines.

The pathophysiology and treatment of active and inactive MS are explored.

Ryan Haumschild, PharmD, MS, MBA, leads a discussion around the epidemiology of multiple sclerosis.

Drs Derek van Amerongen, Soyini Hawkins, Roxie Cannon Wells, and Sharon Deans highlight triple-negative breast cancer among underrepresented patient populations.

The panel highlights initiatives to aid women in early cervical cancer diagnosis and intervention.

An expert panel navigates stigmas and barriers inhibiting patients from achieving optimal care for HIV.

Dr Adam C. Welch drives a discussion highlighting disparities in health care equity affecting patients who receive an HIV diagnosis.

Wanda Filer, MD, MBA, FAAFP, provides an overview of the potential outcomes for patients of all ages with RSV.

Key opinion leaders discuss ongoing clinical trials for respiratory syncytial virus vaccines.

The panel discusses potential therapy options for adults infected with respiratory syncytial virus.

In their final thoughts, medical experts highlight key considerations in the atopic dermatitis (AD) treatment landscape.

Amy Brennan underlines the impact of affordability and how it may be inhibiting the patient atopic dermatitis (AD) treatment process.

Key opinion leaders provide insight on the effect of racial disparities on patients with cervical and breast cancer.

Experts expand on racial and social factors influencing maternal mortality.

Payor considerations in the treatment of HIV are explored.

A panel of experts open a discussion surrounding the current disease landscape of HIV.

In their closing thoughts, the panelists discuss financial considerations for treating patients with RRMM.

Building strong support systems from both clinical and personal perspectives can drive optimal patient outcomes.

Barriers to sufficient multiple myeloma treatment are explored.

Financial impacts associated with respiratory syncytial virus infection are highlighted.

Dr Welch leads a conversation regarding strategies to increase awareness of respiratory syncytial virus.

Wanda Filer, MD, MBA, FAAFP, discusses the prevalence of RSV.

Expert panelists discuss bridging communication between payers and providers in the AD treatment pathway.

White-glove service provided by local pharmacies can increase convenience for patients navigating atopic dermatitis (AD) treatment options.

Sharon Deans, MD, MPH, MBA, and Roxie Cannon Wells, MD, discuss disparities affecting maternal mortality rates.

Ensuring appropriate pre-pregnancy through postnatal care is critical for optimal health of mother and child.